TGF-β, T-cell tolerance and anti-CD3 therapy

Trends in Molecular Medicine

Volumn 10, Issue 1, 2004, Pages 3-9

  Bommireddy, Ramireddy ^a   Doetschman, Thomas ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CALCIUM; CD3 ANTIBODY; CD40 LIGAND MONOCLONAL ANTIBODY; CYCLOSPORIN A; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FC RECEPTOR; TACROLIMUS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; AUTOIMMUNE DISEASE; CALCIUM CELL LEVEL; DIABETES MELLITUS; DISEASE EXACERBATION; DISEASE MODEL; DRUG MECHANISM; DRUG TARGETING; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; IN VIVO STUDY; INFECTION; LYMPHOCYTE ACTIVATION; NEPHROTOXICITY; NONHUMAN; PHENOTYPE; PROTEIN FUNCTION; REVIEW; SIDE EFFECT; T LYMPHOCYTE;

EID: 0742269689     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2003.11.007     Document Type: Short Survey

References (51)

1. Belghith M., et al. TGF-β-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes. Nat. Med. 9:2003;1202-1208.
2. Stockinger B. T lymphocyte tolerance: from thymic deletion to peripheral control mechanisms. Adv. Immunol. 71:1999;229-265.
3. Bonomo A., et al. Premature escape of double-positive thymocytes to the periphery of young mice. Possible role in autoimmunity. J. Immunol. 152:1994;1509-1514.
4. Wood K.J., Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat. Rev. Immunol. 3:2003;199-210.
5. + suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2:2002;389-400.
6. Chiang Y.J., et al. Cbl-b regulates the CD28 dependence of T-cell activation. Nature. 403:2000;216-220.
7. Demetriou M., et al. Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature. 409:2001;733-739.
8. Kane L.P., et al. Signal transduction by the TCR for antigen. Curr. Opin. Immunol. 12:2000;242-249.
9. Prud'homme G.J., Piccirillo C.A. The inhibitory effects of transforming growth factor-β1 (TGF-β1) in autoimmune diseases. J. Autoimmun. 14:2000;23-42.
10. Grewal I.S., et al. Expression of transgene encoded TGF-β in islets prevents autoimmune diabetes in NOD mice by a local mechanism. J. Autoimmun. 19:2002;9-22.
11. Hori S., et al. Control of regulatory T cell development by the transcription factor Foxp3. Science. 299:2003;1057-1061.
12. + regulatory T cells is mediated by cell surface-bound transforming growth factor β J. Exp. Med. 194:2001;629-644.
13. Kuhn R., et al. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 75:1993;263-274.
14. Shull M.M., et al. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature. 359:1992;693-699.
15. Kulkarni A.B., et al. Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. U. S. A. 90:1993;770-774.
16. + immunoregulatory T cells that control autoimmune diabetes. Immunity. 12:2000;431-440.
17. + T cells. J. Exp. Med. 188:1998;1849-1857.
18. + regulatory T cells can mediate suppressor function in the absence of transforming growth factor β1 production and responsiveness. J. Exp. Med. 196:2002;237-246.
19. + regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat. Med. 9:2003;1144-1150.
20. + immunoregulatory T cells: new therapeutics for graft-versus-host disease. J. Exp. Med. 196:2002;401-406.
21. Apostolou I., et al. Origin of regulatory T cells with known specificity for antigen. Nat. Immunol. 3:2002;756-763.
22. Tang Q., et al. CD28/B7 regulation of anti-CD3-mediated immunosuppression in vivo. J. Immunol. 170:2003;1510-1516.
23. + regulatory T cells. J. Immunol. 171:2003;3348-3352.
24. + T regulatory cells. Nat. Immunol. 4:2003;337-342.
25. + regulatory T cells. Nat. Immunol. 4:2003;330-336.
26. Gambineri E., et al. Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr. Opin. Rheumatol. 15:2003;430-435.
27. Simpson P.B., et al. Cutting edge: diabetes-associated quantitative trait locus, Idd4, is responsible for the IL-12p40 overexpression defect in nonobese diabetic (NOD) mice. J. Immunol. 171:2003;3333-3337.
28. Taylor P.A., et al. Tolerance induction of alloreactive T cells via ex vivo blockade of the CD40:CD40L costimulatory pathway results in the generation of a potent immune regulatory cell. Blood. 99:2002;4601-4609.
29. Graca L., et al. Cutting edge: anti-CD154 therapeutic antibodies induce infectious transplantation tolerance. J. Immunol. 165:2000;4783-4786.
30. Graca L., et al. Dominant transplantation tolerance. Curr. Opin. Immunol. 15:2003;499-506.
31. - regulatory cells mediate dominant transplantation tolerance. J. Immunol. 168:2002;5558-5565.
32. R cells suppress innate immune pathology through cytokine-dependent mechanisms. J. Exp. Med. 197:2003;111-119.
33. + cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature. 421:2003;388-392.
34. + regulatory T cell-mediated immunosuppression. Cytokine Growth Factor Rev. 14:2003;85-89.
35. + T cells through TGF-β-TGF-β receptor interactions in type 1 diabetes. Proc. Natl. Acad. Sci. U. S. A. 100:2003;10878-10883.
36. Kitani A., et al. Transforming growth factor (TGF)-β1-producing regulatory T cells induce Smad-mediated interleukin 10 secretion that facilitates coordinated immunoregulatory activity and amelioration of TGF-β1-mediated fibrosis. J. Exp. Med. 198:2003;1179-1188.
37. Chung E.J., et al. Transforming growth factor-β induces apoptosis in activated murine T cells through the activation of caspase1-like protease. Cell. Immunol. 204:2000;46-54.
38. Gilbert K.M., et al. Transforming growth factor-β1 induces antigen-specific unresponsiveness in naive T cells. Immunol. Invest. 26:1997;459-472.
39. Engle S.J., et al. Transforming growth factor β1 suppresses nonmetastatic colon cancer at an early stage of tumorigenesis. Cancer Res. 59:1999;3379-3386.
40. Suarez-Pinzon W.L., et al. Gene transfection and expression of transforming growth factor-β1 in nonobese diabetic mouse islets protects β-cells in syngeneic islet grafts from autoimmune destruction. Cell Transplant. 11:2002;519-528.
41. Diebold R.J., et al. Early-onset multifocal inflammation in the transforming growth factor β1-null mouse is lymphocyte mediated. Proc. Natl. Acad. Sci. U. S. A. 92:1995;12215-12219.
42. 2+-Calcineurin- mediated activation in thymocytes. J. Immunol. 170:2003;3645-3652.
43. Bommireddy R., et al. TGF-β1 regulates lymphocyte homeostasis by preventing activation and subsequent apoptosis of peripheral lymphocytes. J. Immunol. 170:2003;4612-4622.
44. 2+ influx, and NFATc translocation causing inhibition of T cell differentiation. J. Exp. Med. 197:2003;1689-1699.
45. 2 prevents graft-versus-host disease by selectively depleting donor T cells activated by recipient alloantigens. J. Immunol. 166:2001;5835-5839.
46. Herold K.C., et al. Activation of human T cells by FcR nonbinding anti-CD3 mAb, hOKT3γ1(Ala-Ala). J. Clin. Invest. 111:2003;409-418.
47. Gorelik L., Flavell R.A. Abrogation of TGFβ signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity. 12:2000;171-181.
48. Lucas P.J., et al. Disruption of T cell homeostasis in mice expressing a T cell-specific dominant negative transforming growth factor βII receptor. J. Exp. Med. 191:2000;1187-1196.
49. Leveen P., et al. Induced disruption of the transforming growth factor β type II receptor gene in mice causes a lethal inflammatory disorder that is transplantable. Blood. 100:2002;560-568.
50. Tivol E.A., et al. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity. 3:1995;541-547.
51. Yang X., et al. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-β EMBO J. 18:1999;1280-1291.